filmov
tv
EASD 24: Kidney, Cardiovascular, Mortality, Metabolic and Safety Results from the FLOW Trial
Показать описание
We are joined by Dr Richard Pratley (AdventHealth Diabetes Institute, US) to discuss the kidney, cardiovascular, metabolic, mortality and safety results from the FLOW trial.
Interview Questions:
1. What is the reasoning behind the FLOW Trial?
2. What was the patient population and study design?
3. What are the key results?
4. Were there any surprising or unexpected findings?
5. What further study is needed?
Recorded remotely from Orlando, 2024.
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
Interview Questions:
1. What is the reasoning behind the FLOW Trial?
2. What was the patient population and study design?
3. What are the key results?
4. Were there any surprising or unexpected findings?
5. What further study is needed?
Recorded remotely from Orlando, 2024.
This content is intended for healthcare professionals only.
Radcliffe brings medical knowledge, insight and innovation to life for CV clinicians around the world, using our communications & creative expertise, our platforms and connections across the community to help transform theory into practice faster.
0:06:40
0:05:38
0:14:11
0:06:49
1:31:02
0:16:17
0:57:22
1:15:02
0:34:04
0:39:11
0:58:16
0:24:20
1:27:30
0:34:54
0:03:34
1:20:31
0:55:23
0:54:16
1:50:21
0:07:49
1:08:54
0:38:48
0:24:04
0:58:25